Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP)

Historical Holders from Q4 2019 to Q3 2025

Symbol
CRBP on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
17.6M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
8.62M
Holdings value
$109M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
78
Number of buys
32
Number of sells
-37
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cormorant Asset Management, LP 13.36% +4.15% $24.4M -$313K 2.34M -1.26% Cormorant Asset Management, LP 11 Dec 2025
CITADEL ADVISORS LLC 5.3% $12.4M 981K Kenneth Griffin 04 Nov 2025
ORBIMED ADVISORS LLC 5.9% $5.31M 718K OrbiMed Capital LLC 31 Dec 2024
VANGUARD GROUP INC 4.89% $4.14M 599K The Vanguard Group 30 Jun 2025
BlackRock, Inc. 2.9% $2.43M 352K BlackRock, Inc. 30 Jun 2025

Institutional Holders of Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 8.62M $109M -$2.07M $12.65 78
2025 Q2 9.06M $62.5M -$8.93M $6.90 78
2025 Q1 10.4M $55.4M -$13.4M $5.31 85
2024 Q4 11M $129M -$16.3M $11.80 98
2024 Q3 11.7M $242M -$44.7M $20.63 106
2024 Q2 10.8M $486M +$101M $45.25 107
2024 Q1 8.53M $335M +$310M $39.24 81
2023 Q4 750K $4.53M +$41K $6.04 32
2023 Q3 743K $5.01M +$30.9K $6.74 26
2023 Q2 739K $5.8M +$132K $7.84 28
2023 Q1 723K $5.26M +$5.26M $7.27 28
2020 Q2 0 $0 -$5.24K 0
2020 Q1 1K $5.24K $5.24 1
2019 Q4 1K $5.46K $5.46 1